A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

In contrast, the vaccines transaction gives GSK a new star product - Bexsero, a new vaccine for prevention of meningitis B. The drug is the first-in-class, and has been given a Breakthrough ...

GSK continued a run of several consecutive quarters ... Shingrix was once again the star performer, up a forecast-beating 18% to reach £769 million in the fourth quarter and knocking on the ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022 ...

British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other most undervalued biotech stocks to invest in. On February 21, Jared Holz, Mizuho Securities ...

GSK exited Kenya in 2023 as part of its restructuring and now supplies its medicines and vaccines through a third-party distributor. Be part of an exclusive group of enthusiasts! Get fresh content ...

The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President Donald Trump's sweeping tariff plan officially came into effect, sending shockwaves ...

Cruz announces that investors with losses related to GSK plc. ("GSK" or the "Company") (NYSE: GSK) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO ...